Skip to content

EUROPE SOINS

Active
Private limited companyfounded 2022active for 4 yearsRue de l'Arsenal(TOU) 11, 7500 Tournai, BelgiumKBO/BCE: BE 0780.975.605

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The annual accounts of EUROPE SOINS for financial year 2025 show a net loss of 83% of total assets and of 50% of the equity at the start of that year. The 2025 annual accounts show equity of €15,000 and a net result of -€30,092. Equity has been shrinking by about 16% per year since 2022. Its solvency ranks better than 33% of 20,678 sector peers (NACE 86, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 27-01-2022 Normal situation
Legal form
Private limited company
Registered office
Rue de l'Arsenal(TOU) 11, 7500 Tournai
Activity
Nursing and midwifery NACE 86940
Establishment unit
2.330.327.901 7500 Tournai, since 27-01-2022
Financial year end
31 December
Peppol
Reachable since 19-12-2025

Board and ownership

Board
  • Sirine Kenza NedjoumDirector · since 27-01-2022

Financial position

53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€22,662
Turnover
≈ €140,000
estimated
Loss
€30,092
▲ 379%
Equity
€15,000
▼ 74.8%
Total assets
€36,114
▼ 46.7%
2025 accounts filed 23 days before the deadline
Filed on 08-07-2026at the National Bank
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €30,092, the second in a row (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €36,114Figures for financial year 2025 (filed on 08-07-2026)Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 13% of micro companies in human health (NACE 86)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 67-33
equity 41.5% of total assets
Liquidity 30-24
short-term debt 58.3% · cash 8.5%
Profitability 4-3
return on assets -83.3%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.3%▲ +0.1 percentage points vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.3%▼ -0.1 percentage points vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.4%▲ +0.1 percentage points vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026highest value 05-2026: 0.1%▼ -0.3 percentage points vs 04-2026lowest value 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €500 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity is ample, with a current ratio of 1.71 (8.27 in 2024), above the usual 1.5. Short-term debt is 58.3% and cash 8.5% of total assets. However, 58.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 34% of them on solvency, 6% on liquidity, 3% on profitability and 8% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Loss of €30,092, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Size: total assets €36,114
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 08-07-2026)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
22232425
2022 to 2025 · latest year -€30,092
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
23 days early
2024
41 days early
2023
14 days early
2022
41 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 30 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Caution: Lower net result than 95% of companies in human healthsector median €60,139 · 20,665 companies -€30,092 View
  • Caution: 2 loss-making years in a rowloss in financial year 2025 -€30,092 View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about EUROPE SOINS

What is the company number of EUROPE SOINS?
The company number of EUROPE SOINS is 0780.975.605. The VAT number is the same number with BE in front: BE 0780.975.605.
Where is EUROPE SOINS based?
The registered office is at Rue de l'Arsenal(TOU) 11, 7500 Tournai.Company details
What does EUROPE SOINS do?
According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
What is the legal form of EUROPE SOINS?
The legal form of EUROPE SOINS is Private limited company (BV).
When was EUROPE SOINS founded?
EUROPE SOINS was founded on 27-01-2022.
Is EUROPE SOINS still active?
Yes, EUROPE SOINS is an active enterprise in the KBO register.
What is the turnover of EUROPE SOINS?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €22,662 and 41 comparable companies (NACE 869). It probably lies between €91,000 and €250,000. It is a rough estimate.Financials
Is EUROPE SOINS profitable?
In financial year 2025, EUROPE SOINS made a loss of €30,092.
Where can I find the annual accounts of EUROPE SOINS?
EUROPE SOINS filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of EUROPE SOINS due?
EUROPE SOINS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as EUROPE SOINS: nursing and midwifery (NACE 86940). They are comparable in size and age: total assets between €33,700 and €40,200, founded between 2021 and 2022.

CompanyTotal assetsGross margin
EUROPE SOINS Tournai€36,114€22,662
FRA NURSING Erquelinnes€33,694€21,152
IVPV Médic Hamois€38,192€21,780
Infermia Dilsen-Stokkem€35,227€20,801
Thuisverpleging Samson Luc Zaventem€37,191€21,453
KokerCare Zottegem€40,218€24,485
BLKD Liège€35,407€21,968
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.